180 Life Sciences Debt 2024

180 Life Sciences Aktienanalyse

What does 180 Life Sciences do?

180 Life Sciences Corp is a US biotechnology company that focuses on the development of treatments for chronic inflammatory diseases. The company was founded in 2018 and is headquartered in New York City. 180 Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding 180 Life Sciences's Debt Structure

180 Life Sciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing 180 Life Sciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to 180 Life Sciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in 180 Life Sciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about 180 Life Sciences stock

What is the debt of 180 Life Sciences this year?

180 Life Sciences has a debt level of -0.92 USD this year.

What was the debt of 180 Life Sciences compared to the previous year?

The debt of 180 Life Sciences has increased by -83.62% compared to the previous year dropped.

What are the consequences of high debt for investors in 180 Life Sciences?

High debt can pose a risk for investors of 180 Life Sciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of 180 Life Sciences?

Low debt means that 180 Life Sciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from 180 Life Sciences affect the company?

An increase in debt of 180 Life Sciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of 180 Life Sciences affect the company?

A reduction in debt of 180 Life Sciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of 180 Life Sciences?

Some factors that can influence the debt of 180 Life Sciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of 180 Life Sciences so important for investors?

The debts of 180 Life Sciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can 180 Life Sciences take to change the debt?

To change the debt, 180 Life Sciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does 180 Life Sciences pay?

Over the past 12 months, 180 Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 180 Life Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of 180 Life Sciences?

The current dividend yield of 180 Life Sciences is .

When does 180 Life Sciences pay dividends?

180 Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 180 Life Sciences?

180 Life Sciences paid dividends every year for the past 0 years.

What is the dividend of 180 Life Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 180 Life Sciences located?

180 Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von 180 Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 180 Life Sciences from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did 180 Life Sciences pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of 180 Life Sciences in the year 2023?

In the year 2023, 180 Life Sciences distributed 0 USD as dividends.

In which currency does 180 Life Sciences pay out the dividend?

The dividends of 180 Life Sciences are distributed in USD.